selpercatinib
servier,eli lilly
['indigo', 'paradigm']
 here's an intvw. at #asco23 with dr. peters about her presentation on findings from the indigo trial, which provide potential to change the treatment paradigm for low-grade #glioma 
Cancer creates its own rules. We recognized ending cancer requires a weapon as adaptable & multiform as the disease itself—Duke Cancer Institute.